Author:
Wang Guanghui,Zeng Yukai,Zheng Haotian,Zhao Xiaogang,Wang Yadong,Shen Hongchang,Du Jiajun
Funder
Jinan Science and Technology Plan
the Natural Science Foundation of Shandong Province
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery
Reference16 articles.
1. Qu J, Wang L, Jiang M, Zhao D, Wang Y, Zhang F, Li J, Zhang X. A review about pembrolizumab in first-line treatment of advanced NSCLC: focus on KEYNOTE studies. Cancer Manag Res. 2020. https://doi.org/10.2147/CMAR.S257188.
2. Wang H, Hou J, Zhang G, Zhang M, Li P, Yan X, Ma Z. Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in patients with lung cancer. Cancer Gene Ther. 2019;11:26.
3. Surapaneni R, Singh P, Rajagopalan K, Hageboutros A. Stage I lung cancer survivorship: risk of second malignancies and need for individualized care plan. J Thorac Oncol. 2012;7(8):1252–6.
4. Hamaji M, Allen MS, Cassivi SD, Deschamps C, Nichols FC, Wigle DA, Shen KR. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2013. https://doi.org/10.1016/j.jtcvs.2012.12.051.
5. Shintani Y, Okami J, Ito H, et al. Clinical features and outcomes of patients with stage I multiple primary lung cancers. Cancer Sci. 2020. https://doi.org/10.1111/cas.14748.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献